Literature DB >> 9097437

Infection of Acanthamoeba castellanii by Chlamydia pneumoniae.

A Essig1, M Heinemann, U Simnacher, R Marre.   

Abstract

Chlamydia pneumoniae is an intracellular respiratory pathogen, which, similar to Legionella, might have developed mechanisms to escape the intracellular bactericidal activity of both human host cells and amoeba. We therefore investigated the intracellular growth and survival of C. pneumoniae in Acanthamoeba castellanii by using cell culture, immunofluorescence microscopy, and electron microscopy. A castellanii was incubated with purified elementary bodies of C. pneumoniae TW 183 at a concentration of 10(6) inclusion-forming units (IFU)/ml to give a ratio of approximately 1 IFU of C. pneumoniae per amoeba. Quantitative determination of chlamydial growth within A. castellanii revealed viable and infective C. pneumoniae in the range of 10(4) to 10(5) IFU/ml between days 7 and 14 postinfection. Immunofluorescence analysis and transmission electron microscopy with subsequent immunogold staining confirmed evidence of infection of the amoebae by C. Pneumoniae and additionally revealed that C. pneumoniae entered the typical growth cycle. Our results show that amoebae allow the survival of C. pneumoniae, suggesting that amoebae may serve as an additional reservoir for Chlamydia or Chlamydia-related organisms.

Entities:  

Mesh:

Year:  1997        PMID: 9097437      PMCID: PMC168434          DOI: 10.1128/aem.63.4.1396-1399.1997

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  25 in total

1.  Concurrent chlamydial and Acanthamoeba keratoconjunctivitis.

Authors:  V M Reddy; J S Pepose; A J Lubniewski; L A Gans; M E Smith
Journal:  Am J Ophthalmol       Date:  1991-10-15       Impact factor: 5.258

2.  Legionella pneumophila mip gene potentiates intracellular infection of protozoa and human macrophages.

Authors:  N P Cianciotto; B S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  A quantitative model of intracellular growth of Legionella pneumophila in Acanthamoeba castellanii.

Authors:  J F Moffat; L S Tompkins
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

4.  Transmission of Chlamydia pneumoniae.

Authors:  A R Falsey; E E Walsh
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

5.  Identification of mip-like genes in the genus Legionella.

Authors:  N P Cianciotto; J M Bangsborg; B I Eisenstein; N C Engleberg
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

6.  Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

7.  A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same specificity as its natural counterpart.

Authors:  Y Fu; M Baumann; P Kosma; L Brade; H Brade
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.

Authors:  M B Aldous; J T Grayston; S P Wang; H M Foy
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

9.  Spread of subclinical Chlamydia pneumoniae infection in a closed community.

Authors:  B P Berdal; O Scheel; A R Ogaard; T Hoel; T J Gutteberg; G Anestad
Journal:  Scand J Infect Dis       Date:  1992

10.  The Chlamydia trachomatis Mip-like protein is a lipoprotein.

Authors:  A G Lundemose; D A Rouch; C W Penn; J H Pearce
Journal:  J Bacteriol       Date:  1993-06       Impact factor: 3.490

View more
  34 in total

1.  Does amoeboid reasoning explain the evolution and maintenance of virulence factors in Cryptococcus neoformans?

Authors:  S M Levitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Phylogenetic diversity among geographically dispersed Chlamydiales endosymbionts recovered from clinical and environmental isolates of Acanthamoeba spp.

Authors:  T R Fritsche; M Horn; M Wagner; R P Herwig; K H Schleifer; R K Gautom
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

3.  Legionella pneumophila utilizes the same genes to multiply within Acanthamoeba castellanii and human macrophages.

Authors:  G Segal; H A Shuman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 4.  Microorganisms resistant to free-living amoebae.

Authors:  Gilbert Greub; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

5.  Interaction of Pasteurella multocida with free-living amoebae.

Authors:  Matthew J Hundt; Carmel G Ruffolo
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

6.  Chlamydophila pneumoniae antibodies in office workers with and without inflammatory rheumatic diseases in a moisture-damaged building.

Authors:  M Seuri; M Paldanius; M Leinonen; M Roponen; M-R Hirvonen; P Saikku
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

Review 7.  Amoebae as training grounds for intracellular bacterial pathogens.

Authors:  Maëlle Molmeret; Matthias Horn; Michael Wagner; Marina Santic; Yousef Abu Kwaik
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

8.  Infection of Acanthamoeba castellanii with Mycobacterium bovis and M. bovis BCG and survival of M. bovis within the amoebae.

Authors:  Stephanie J Taylor; Leena J Ahonen; Frans A A M de Leij; Jeremy W Dale
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

Review 9.  Pathogenic free-living amoebae in Korea.

Authors:  Ho-Joon Shin; Kyung-il Im
Journal:  Korean J Parasitol       Date:  2004-09       Impact factor: 1.341

Review 10.  Parachlamydiaceae: potential emerging pathogens.

Authors:  Gilbert Greub; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.